EPO and metabolic syndrome: It has been suggested that RDW increase is associated with impaired erythropoiesis due to underlying metabolic abnormalities such as oxidative stress, inflammation, malnutrition, dyslipidemia, erythrocyte fragmentation and impaired erythropoietin function [6,15,16].